Structure Therapeutics Oral GLP-1 Obesity Drug Achieves ‘Injectable-Like Efficacy’ in Phase 2 Test
Construction Therapeutics’ aleniglipron, a once-daily oral GLP-1 drug, led to a mean 16% weight reduction measured at 44 weeks. Primarily ...
Construction Therapeutics’ aleniglipron, a once-daily oral GLP-1 drug, led to a mean 16% weight reduction measured at 44 weeks. Primarily ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.